FDA, CDC call for pause in use of Johnson & Johnson vaccine after six reported cases of rare blood clots

The Food and Drug Administration and Centers for Disease Control and Prevention said Tuesday they are reviewing data involving six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the Johnson & Johnson vaccine.

Comments are closed.